Thursday 17 November
9am EST | 2pm GMT | 3pm CET | 5pm EAT | 7:30pm IST (1 hour)
Thank you for joining us for our 1st ‘Young ISSAD’ Committee Seminar Series on GBS Epidemiology. We had speakers Dr Proma Paul, London School of Hygiene & Tropical Medicine and Dr Lesly McGee, Centre for Disease Control, join us for our first event on World Prematurity Day.
Dr Proma Paul (LSHTM) is currently a research fellow and the multi-country GBS long-term outcome study coordinator. The study looks at the developmental outcomes of survivors of invasive GBS disease in early infancy in Argentina, India, Kenya, Mozambique, and South Africa.
Dr Lesley McGee is the team lead for the US Centers for Disease Control and Prevention’s Streptococcus Laboratory. Her role includes routine surveillance, research, and public health response to Streptococcus pneumoniae and groups A and B streptococcus. She has worked extensively in streptococcal disease surveillance, focusing on pathogen detection, antimicrobial resistance, molecular epidemiology and evolution and genomics.
The event is FREE to attend for all!
|1. Welcome – Dr Natália Costa, Universidade Federal do Rio de Janeiro|
|2. Neurodevelopmental outcomes of survivors of invasive Group B Streptococcal disease in infants: findings from high and low income settings – Dr Proma Paul, London School of Hygiene & Tropical Medicine|
|3. Strain features of Group B Streptococci from CDC’s US ABCs program using whole genome sequencing approach – Dr Lesley McGee, US Centers for Disease Control|
|4. Q&A with speakers – Dr Laura Oliveira, Universidade Federal do Rio de Janeiro|
|5. Closing remarks – Chaired by Dr Ana Caroline Botelho, Universidade Federal do Rio de Janeiro|